Novavax

News

Investor seeks sale of Novavax after poor COVID jab sales

Investor Shah Capital has called on Novavax's board to put the company up for sale, citing a "litany of missteps" at the vaccine developer.

News

FDA finally okays Novavax's COVID-19 jab, with restrictions

The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.

News

Medical gloved hands fill a vaccine into a syringe

Does the Novavax delay augur a COVID vaccine policy change?

Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.

News

COVID-19 vaccinations now ‘alarmingly low’ in Europe

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

News

Novavax investor withdraws proxy fight after Sanofi deal

Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the wake of its $1.2 billion alliance with Sanofi.

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

Investor seeks sale of Novavax after poor COVID jab sales

FDA finally okays Novavax's COVID-19 jab, with restrictions

Does the Novavax delay augur a COVID vaccine policy change?

COVID-19 vaccinations now ‘alarmingly low’ in Europe

Novavax investor withdraws proxy fight after Sanofi deal

Sanofi forges $1.2bn alliance with vaccines firm Novavax

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Novavax

Editor's Picks